Table 2.
Cumulative Hazard Ratio | 95%CI | QT (heterogeneity) | |
---|---|---|---|
All effects (k=15) | 1.42* | 1.20 – 1.67 | 61.61* |
Using study as the unit of analysis (K=9) | 1.38* | 1.15 – 1.66 | 52.11* |
Participants | |||
Sexa | |||
Women (k=3) | 1.62* | 1.08 – 2.43 | 6.30* |
Men (k=2) | 1.01 | .59 – 1.73 | .002 |
QM (1, 3) | 1.92 | ||
Outcomec | |||
Type | |||
Metabolic outcomes (k=3) | 1.63* | 1.16 – 2.29 | 10.89* |
CVD clinical outcomes (k=12) | 1.36* | 1.13 – 1.63 | 41.11* |
QM (1, 13) | .84 | ||
Measurement | |||
Self-report (k=7) | 1.59* | 1.23 – 2.05 | 42.91* |
Independently-assessed disease (k=8) | 1.30* | 1.02 – 1.66 | 15.51* |
QM (1, 13) | 1.26 | ||
Cumulative Adversity Index | |||
Type of Adversity Measure | |||
ACE Study Questionnaire (k=3) | 3.41* | 2.31 – 5.03 | 1.81 |
Other Scale/Ad-hoc Composite (k=12) | 1.23* | 1.09 – 1.38 | 24.44* |
QM (1, 13) | 24.29* | ||
Index Included Childhood SES | |||
No (k=4) | 2.26* | 1.66 – 3.07 | 19.11* |
Yes (k=11) | 1.22* | 1.04 – 1.43 | 19.46* |
QM (1, 13) | 12.13* | ||
Index Included Household Dysfunction | |||
No (k=5) | 1.16 | 0.86 – 1.56 | 5.63 |
Yes (k=10) | 1.61* | 1.29 – 2.01 | 55.74* |
QM (1, 13) | 3.04† | ||
Index Included Abuse/Neglect | |||
No (k=7) | 1.27* | .98 – 1.66 | 14.21* |
Yes (k=8) | 1.56* | 1.24 – 1.96 | 46.99* |
QM (1, 13) | 1.28 | ||
Analytic Strategy | |||
Number of Covariates in Analytic Models | |||
5 or fewer (k=5) | 1.99* | 1.48 – 2.62 | 27.48* |
6 or more (k=10) | 1.22* | 1.01 – 1.47 | 19.49* |
QM (1, 13) | 7.48* | ||
Psychosocial Covariate | |||
No (k=4) | 2.26* | 1.66 – 3.07 | 19.11* |
Yes (k=11) | 1.22* | 1.04 – 1.43 | 19.46* |
QM (1, 13) | 12.13* | ||
Health Behavior Covariate | |||
No (k=5) | 1.97* | 1.48 – 2.62 | 27.48* |
Yes (k=10) | 1.22* | 1.01 – 1.47 | 19.49* |
QM (1, 13) | 7.48* |
Note. QM = test of between group difference. K denotes studies and k denotes effects (i.e., cumulative adversity on one outcome). Cumulative effect sizes are represented using hazard ratios. Results reflect estimated effects of cumulative adversity on combined cardiometabolic outcomes, with the exception of results for moderation by “Outcome Type.” Bolded values highlight significant moderator variables.
Greater than 80% of the sample had to be of the same sex or results presented separately by sex to code the sample as predominantly composed of men or women.
p<.05.
p<.10.